MARKET

SRZN

SRZN

Surrozen Inc
NASDAQ
31.61
-0.06
-0.19%
After Hours: 31.61 0 0.00% 19:30 11/13 EST
OPEN
32.34
PREV CLOSE
31.67
HIGH
32.87
LOW
30.40
VOLUME
106.75K
TURNOVER
--
52 WEEK HIGH
37.83
52 WEEK LOW
11.66
MARKET CAP
602.54M
P/E (TTM)
-0.8833
1D
5D
1M
3M
1Y
5Y
1D
Surrozen prices 1.89M shares of common stock at $31.67
TipRanks · 2d ago
Surrozen Is Maintained at Buy by Guggenheim
Dow Jones · 3d ago
Guggenheim Maintains Buy on Surrozen, Raises Price Target to $80
Benzinga · 3d ago
Surrozen (SRZN) Receives a Buy from Guggenheim
TipRanks · 3d ago
Surrozen price target raised to $80 from $42 at Guggenheim
TipRanks · 3d ago
Surrozen reports Q3 EPS ($11.02) vs. ($8.36) last eyar
TipRanks · 5d ago
Surrozen Price Target Raised to $62.00/Share From $40.00 by Cantor Fitzgerald
Dow Jones · 5d ago
Surrozen Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones · 5d ago
More
About SRZN
Surrozen, Inc. is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. The Company is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with a focus in ophthalmology. Its product candidates include SZN-8141 for Retinal Diseases, SZN-8143 for Retinal Diseases, SZN-113 for Fuchs’ Endothelial Corneal Dystrophy and Geographic Atrophy, and SZN-413 for Retinal Diseases. SZN-8141 combines Frizzled 4 (Fzd4) agonism and Vascular Endothelial Growth Factor (VEGF) antagonism which has the potential to provide benefits over treatment with single agents for Diabetic Macular Edema (DME) and neovascular Age Related Macular Degeneration (wet AMD). SZN-8143 combines Fzd4 agonism, VEGF antagonism, and interleukin-6 (IL-6) antagonism which may have benefits over single agents for treatment of DME/wet AMD/uveitic macular edema. SZN-413 is a bi-specific antibody, designed using its SWAP technology.

Webull offers Surrozen Inc stock information, including NASDAQ: SRZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRZN stock methods without spending real money on the virtual paper trading platform.